Skip to main content
. 2010 Aug 16;28(27):4240–4246. doi: 10.1200/JCO.2010.30.4154

Table 3.

Reported Incidence of Clinical Hyperglycemia/Diabetes

Hyperglycemia Arm A:IMC-A12 (n = 23)
Arm B: IMC-A12 + Cetuximab (n = 21)
Arm C: IMC-A12 + Cetuximab and KRAS Wild Type (n = 20)
Total
No. % No. % No. % No. %
Grade 1 0 0 0 0
Grade 2 0 1 5 1 5 2 3
Grade 3 1 4 0 0 1 2
Grade 4 0 0 0 0
Grade 5 0 0 0 0